Sanguine Corp.

Download Sanguine's Latest Shareholder Letter
 

Sanguine Corporation's PHER-O2 is the second generation of the only blood supplement to achieve FDA approval.

 

Products

News

Management

Investors

About Us

 

 

line.gif (41 bytes)
Copyright 2006 Sanguine Corp. Products | News | Management | Investors | About Us